Moderna Archives -

News/ News/ R&D

Moderna’s HIV vaccine prepped for trials in Africa

Phil Taylor HIV, infectious disease, Moderna, mRNA, vaccine 0 Comment

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV

Moderna’s HIV vaccine prepped for trials in Africa

https://pharmaphorum.com/news/modernas-hiv-vaccine-prepped-for-trials-in-africa/

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

News/ News/ Patients

COV-BOOST trial data show value of fourth dose

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Moderna, Pfizer 0 Comment

Administering a fourth dose of an mRNA COVID-19 vaccine provides a stronger level of protection than a third

COV-BOOST trial data show value of fourth dose

https://pharmaphorum.com/news/cov-boost-trial-data-show-value-of-fourth-dose/

News/ News/ News/ Patients/ R&D

Moderna unveils first clinical data on bivalent COVID variant booster

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, Moderna, Omicron, Spikevax 0 Comment

Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original

Moderna unveils first clinical data on bivalent COVID variant booster

https://pharmaphorum.com/news/moderna-unveils-first-clinical-data-on-bivalent-covid-variant-booster/

News/ News/ Patients

EU says not enough evidence to warrant fourth COVID jabs

Phil Taylor BioNTech, Comirnaty, coronavirus, COVID-19, COVID-19 vaccine, ema, fda, Moderna, Pfizer, Spikevax 0 Comment

It is too early to consider widespread use of a second COVID-19 vaccine booster dose, according to the

EU says not enough evidence to warrant fourth COVID jabs

https://pharmaphorum.com/news/eu-says-not-enough-evidence-to-warrant-fourth-covid-jabs/

News/ News/ Sales and Marketing

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China deal

Phil Taylor Bavarian Nordic, GlaxoSmithKline, Johnson & Johnson, licensing, Moderna, Nuance Pharma, Pfizer, respiratory syncytial virus, vaccine 0 Comment

Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China deal

https://pharmaphorum.com/news/trailing-its-rsv-vaccine-rivals-bavarian-nordic-cuts-china-deal/

Market Access/ News/ News

Moderna follows Pfizer in asking FDA for second COVID booster okay

Phil Taylor BioNTech, Comirnaty, coronavirus, COVID-19, COVID-19 vaccine, Moderna, Pfizer, Spikevax 0 Comment

Moderna has asked the FDA for emergency use authorisation for a fourth dose of its mRNA COVID-19 vaccine

Moderna follows Pfizer in asking FDA for second COVID booster okay

https://pharmaphorum.com/news/moderna-follows-pfizer-in-asking-fda-for-second-covid-booster-okay/

News/ News/ Sales and Marketing

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

Phil Taylor Alnylam Pharmaceuticals, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, drug delivery, Moderna, mRNA, patent litigation, Pfizer 0 Comment

Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

https://pharmaphorum.com/news/alnylam-sues-pfizer-moderna-over-covid-19-vaccines/

R&D/ Views & Analysis/ Views and analysis

Does the pandemic mark a turning point in vaccine development?

Ben Hargreaves COVID-19, Moderna, Pfixer, vaccine 0 Comment

After a period where vaccine development had fallen away, suddenly it is back in the limelight. Investment has

Does the pandemic mark a turning point in vaccine development?

https://pharmaphorum.com/r-d/does-the-pandemic-mark-a-turning-point-in-vaccine-development/

News/ News/ R&D

Moderna targets 15 pathogens in ‘global public health strategy’

Phil Taylor emerging markets, infectious disease, Moderna, mRNA 0 Comment

Moderna has unveiled plans to start clinical trials of mRNA-based vaccines for 15 infectious diseases that pose the

Moderna targets 15 pathogens in ‘global public health strategy’

https://pharmaphorum.com/news/moderna-targets-15-pathogens-in-global-public-health-strategy/

Trending

Moderna

Login